Dr Reddy’s acquires India trademarks for 2 HRT drugs from UK’s Mercury Pharma for $32 million
Dr Reddy’s Laboratories Ltd is foraying into the hormone replacement therapy (HRT) segment in India with the acquisition of the trademarks and related assets for Progynova and Cyclo‑Progynova from UK-headquartered Mercury Pharma Group Limited for a consideration of $32.15 million (approx Rs 295 crore).The move is aimed at strengthening its gynaecology portfolio and serving as … Read more